cellular
membran
constitut
physic
barrier
viral
infect
envelop
virus
develop
special
protein
overcom
barrier
protein
often
extens
glycosyl
insert
viral
membran
mediat
recognit
target
cell
fusion
viral
membran
host
cell
membran
latter
process
allow
introduct
viral
genom
associ
viral
protein
host
cell
lumen
therefor
critic
establish
product
infect
case
coronavirus
cov
term
spike
protein
attract
target
inhibitor
vaccin
envelop
virus
evolv
two
prototyp
glycoprotein
enter
target
cell
term
class
class
ii
fusion
protein
class
fusion
protein
found
eg
retrovirus
paramyxovirus
eg
flavivirus
alphavirus
encod
class
ii
fusion
protein
type
fusion
protein
exhibit
distinct
function
organ
reflect
differ
spatial
orient
thu
class
fusion
protein
orient
perpendicular
cellular
membran
visibl
spike
electron
micrograph
class
ii
protein
orient
horizont
rel
cellular
membran
well
order
virion
surfac
viral
class
fusion
protein
organ
globular
surfac
unit
su
interact
cellular
receptor
transmembran
unit
tm
harbor
highli
conserv
sequenc
element
requir
membran
fusion
membran
fusion
initi
bind
su
cellular
receptor
exposur
glycoprotein
low
ph
trigger
conform
chang
glycoprotein
activ
tm
tmdriven
membran
fusion
initi
insert
ntermin
fusion
peptid
target
cell
membran
follow
conform
chang
tm
two
heptad
repeat
extracellular
part
tm
fold
back
onto
pull
viral
target
cell
membran
close
contact
ultim
promot
membran
fusion
despit
differ
function
organ
class
ii
fusion
protein
eg
harbor
fusion
peptid
su
membran
fusion
driven
protein
follow
similar
principl
sprotein
cov
protrud
viral
membran
provid
viru
particl
typic
corona
like
shape
exhibit
characterist
class
fusion
protein
sprotein
cleav
case
human
coronaviru
cleavag
possibl
import
function
contrast
cleavag
spike
protein
group
cov
observ
cleavag
mous
hepat
viru
mhv
appear
celltyp
depend
essenti
function
domain
adapt
bind
specif
cellular
receptor
spikereceptor
interact
major
determin
viral
cell
tropism
sprotein
cov
differ
group
case
adapt
interact
differ
receptor
show
littl
sequenc
conserv
contrast
domain
share
task
fusion
viral
cellular
membran
therefor
exhibit
consider
sequenc
homolog
infect
individu
contrast
infect
caus
sever
diseas
often
associ
bronchiol
cold
like
symptom
although
sarscov
mainli
due
air
travel
spread
differ
countri
major
case
observ
asia
turn
seem
global
distribut
pathogen
infect
report
europ
japan
canada
australia
sequenc
analysi
reveal
also
sprotein
sarscov
exhibit
featur
class
fusion
protein
thu
subunit
contain
heptad
repeat
transmembran
domain
short
intracellular
domain
element
found
subunit
cov
sprotein
subunit
sarscov
littl
sequenc
homolog
cov
sprotein
contrast
sequenc
aminopeptidas
entri
target
cell
thought
investig
rang
target
cell
suscept
sarscov
depend
infect
well
interact
respect
sprotein
cellular
membran
protein
recognit
sera
infect
patient
analys
employ
retrovir
report
virus
pseudotyp
covsprotein
virus
call
pseudotyp
gener
cotransfect
cell
plasmid
encod
retrovir
genom
env
open
read
frame
inactiv
report
gene
insert
togeth
express
plasmid
covsprotein
studi
particl
harbor
cov
sprotein
membran
enter
target
cell
sprotein
depend
manner
howev
membran
fusion
complet
process
lead
viral
gene
express
depend
retrovir
protein
effici
infect
pseudotyp
virus
conveni
quantifi
express
report
gene
encod
provir
genom
sarscov
infect
lower
respiratori
tract
fatal
outcom
engag
angiotensin
convert
enzym
receptor
cellular
entri
share
subunit
ident
employ
employ
deriv
report
virus
harbor
sprotein
sarscov
frankfurt
strain
investig
rang
cell
permiss
sarscov
depend
infect
pseudotyp
bear
gprotein
amphotrop
vesicular
stomat
viru
vsv
use
posit
control
virus
without
envelop
protein
employ
neg
control
infect
panel
cell
line
reveal
sarscov
mediat
effici
entri
liver
kidney
deriv
cell
line
hepatoma
cell
line
found
permiss
sarscov
replic
entri
liver
kidney
deriv
cell
line
agreement
subsequ
studi
demonstr
infect
organ
sar
patient
contrast
lymphoid
cell
line
refractori
sarscov
driven
infect
similar
observ
made
independ
studi
examin
replic
compet
sarscov
suggest
lymphoid
cell
might
support
sarscov
spread
vivo
next
determin
sarscov
driven
cellular
entri
depend
acid
environ
address
question
cell
preincub
lysosomotrop
agent
ammonium
chlorid
bafilomycin
infect
sarscov
vsvg
murin
leukemia
viru
mlv
bear
pseudotyp
agreement
publish
data
entri
mediat
mlv
glycoprotein
block
lysosomotrop
agent
entri
driven
vsvg
effici
inhibit
dose
depend
manner
infecti
entri
sarscov
bear
pseudotyp
unfold
fusogen
activ
observ
confirm
sever
independ
studi
final
investig
sera
sar
patient
recogn
sarscov
protein
neutral
infect
transient
express
sarscov
cell
follow
stain
cell
sera
healthi
patient
sar
patient
reveal
sar
patient
sera
recogn
sprotein
sera
sar
patient
control
sera
neutral
sarscov
depend
infect
indic
infect
individu
mount
sspecif
neutral
antibodi
respons
studi
li
colleagu
reveal
sarscov
employ
entri
target
cell
specif
subunit
shown
bind
fusion
sarscov
express
cell
control
cell
demonstr
inhibit
analysi
indic
replic
sarscov
depend
amino
acid
sarscov
shown
function
independ
receptor
bind
domain
studi
indic
import
receptor
sarscov
unclear
viru
engag
receptor
besid
infect
target
cell
therefor
investig
express
correl
permiss
sarscov
depend
infect
analysi
mrna
express
panel
cell
line
known
suscept
sarscov
mediat
entri
reveal
sarscov
bear
pseudotyp
infect
exclus
cell
line
express
also
block
indic
sarscov
protein
requir
low
ph
environ
find
suggest
paramount
import
sarscov
entri
like
constitut
receptor
sarscov
find
substanti
sever
subsequ
studi
interact
sarscov
attract
target
therapeut
intervent
inde
sever
studi
describ
peptid
inhibitor
mimic
second
heptad
repeat
subunit
sarscov
block
sarscov
infect
low
micromolar
rang
investig
inhibitor
base
ectodomain
might
also
effect
end
incub
sarscov
vsvg
bear
pseudotyp
concentr
solubl
ectodomain
analys
infect
target
cell
ectodomain
inhibit
sarscov
potent
specif
manner
suggest
polypeptid
base
ectodomain
could
least
theori
develop
therapeut
final
ask
cytoplasm
domain
harbor
consensu
site
tyrosin
kinas
casein
kinas
ii
motif
requir
receptor
function
howev
variant
cytoplasm
tail
stepwis
delet
fulli
capabl
promot
sarscov
depend
entri
transient
transfect
cell
indic
cytoplasm
domain
might
dispens
receptor
function
least
condit
overexpress
alreadi
permiss
cell
engag
cellular
receptor
viral
glycoprotein
essenti
viru
entri
target
cell
howev
engag
cellular
factor
viral
receptor
affect
infect
effici
thu
bind
call
attach
factor
concentr
virus
surfac
target
cell
therebi
increas
chanc
receptor
engag
subsequ
infecti
entri
lectin
dcsign
univers
pathogen
attach
factor
promot
infect
varieti
viral
non
viral
pathogen
mayb
strikingli
dcsign
express
dendrit
cell
dc
facilit
hiv
interact
cell
believ
import
viral
dissemin
dcsign
bind
highmannos
carbohydr
hivenv
protein
facilit
infect
dcsign
express
cell
case
also
express
hiv
receptor
adjac
suscept
cell
former
process
term
infect
ci
latter
process
term
infect
pathogen
attach
factor
contrast
dcsign
dcsignr
express
sinusoid
endotheli
cell
lymph
node
liver
hepatotrop
virus
analysi
posit
cell
express
dcsign
dcsignr
control
plasmid
reveal
lectin
bind
unit
sarscov
augment
sarscov
depend
infect
importantli
howev
express
dcsign
dcsignr
nonpermiss
cell
allow
readili
detect
sarscov
mediat
infecti
entri
dcsign
posit
immatur
dc
refractori
infect
indic
dcsign
dcsignr
function
sarscov
attach
factor
viral
receptor
dcsign
express
nonpermiss
cell
might
promot
spread
tran
transmiss
apart
dcsign
relat
protein
dcsignr
dcsignrel
also
term
lsign
liversign
also
shown
function
dc
transmit
sarscov
bear
pseudotyp
replic
compet
sarscov
adjac
permiss
cell
indic
dc
might
promot
sarscov
dissemin
infect
individu
similarli
dcsignr
express
lung
might
promot
sarscov
spread
major
target
organ
monkey
kidney
cell
shown
permiss
infect
howev
rang
suscept
target
cell
identifi
order
analyz
cellular
tropism
employ
lentivir
pseudotyp
carri
sprotein
includ
virion
pseudotyp
sarscov
control
latter
sprotein
highli
homolog
suggest
might
employ
cellular
receptor
entri
might
thu
enter
target
cell
howev
observ
strike
differ
cell
tropism
bear
pseudotyp
tabl
ho
felin
fcwf
cell
suscept
infect
wherea
mediat
entri
kidney
cell
interestingli
cell
tropism
harbor
pseudotyp
match
previous
describ
sarscov
bear
pseudovirion
suggest
sprotein
might
engag
cellular
factor
entri
next
address
bear
pseudotyp
reflect
cell
tropism
replic
compet
cell
highli
permiss
sarscov
driven
infect
therefor
expect
replic
cell
inde
four
five
day
inocul
cytopath
effect
readili
visibl
infect
cultur
comparison
mockinfect
cell
indic
hepat
cell
tropism
bear
pseudoparticl
reflect
replicationcompet
tabl
analysi
cell
tropism
covspseudotyp
indic
cell
line
infect
lentivir
pseudotyp
carri
sprotein
sarscov
report
gene
activ
cellular
lysat
quantifi
infect
effici
shown
infect
low
high
cell
line
sarscov
bear
pseudotyp
exhibit
compar
cell
tropism
next
ask
entri
mediat
sprotein
depend
low
ph
address
question
target
cell
incub
lysosomotrop
agent
bafilomycin
ammonium
chlorid
infect
pseudovirion
bear
vsvg
mlv
spike
protein
sarscov
data
shown
expect
vsvg
driven
entri
inhibit
lysosomotrop
agent
mlv
glycoprotein
depend
entri
affect
entri
mediat
cov
sprotein
examin
depend
low
ph
suggest
sarscov
employ
rout
entri
felin
serv
receptor
cov
phylogenet
group
group
viru
expect
might
also
engag
entri
cell
tropism
experi
describ
howev
observ
felin
fcwf
cell
express
refractori
mediat
infect
similarli
cell
overexpress
human
permiss
mediat
infect
express
felin
human
augment
infect
driven
indic
involv
entri
cellular
tropism
sarscov
bear
pseudotyp
ident
next
investig
sarscov
receptor
play
role
depend
entri
address
question
transient
express
cell
overinfect
cell
sarscov
bear
pseudotyp
herebi
signific
enhanc
infect
could
document
sarscov
pseudotyp
interact
specif
express
close
relat
protein
allow
augment
infect
addit
abl
inhibit
mediat
entri
replic
antiserum
antibodi
direct
confirm
specif
interact
final
employ
solubl
protein
investig
directli
interact
sarscov
bound
effici
cell
express
control
cell
indic
directli
contact
next
address
question
whether
alon
suffici
mediat
entri
transient
express
nonpermiss
hela
cell
follow
infect
sarss
bear
pseudotyp
wherea
presenc
allow
effici
sarssmedi
entri
observ
slight
enhanc
depend
entri
data
shown
find
explain
three
way
sarss
exhibit
higher
affin
ii
much
higher
amount
present
target
cell
effici
mediat
entri
compar
sarscov
driven
infect
iii
requir
far
unidentifi
coreceptor
insuffici
present
hela
cell
addit
possibl
cellular
factor
involv
step
receptor
engag
might
critic
mediat
infect
could
dispens
sarss
depend
cellular
entri
experi
requir
deciph
differ
sarscov
entri
target
cell
initi
pcrbase
screen
experi
suggest
infect
rel
frequent
serolog
data
includ
studi
employ
bear
pseudoparticl
investig
whether
adult
without
respiratori
tract
ill
exhibit
neutral
antibodi
respons
interestingli
found
strong
neutral
activ
sera
adult
test
therefor
infect
seem
frequent
preval
infect
furthermor
sera
neutral
depend
infect
necessarili
block
mediat
infecti
entri
suggest
crossreact
antibodi
induc
infect
individu
despit
high
amino
acid
similar
sprotein
investig
sera
children
differ
age
group
observ
neutral
antibodi
respons
first
detect
age
year
found
sampl
donor
age
least
year
contrast
none
sera
investig
show
reactiv
sarscov
indic
sarscov
despit
use
receptor
cellular
entri
share
determin
recogn
neutral
antibodi
employ
retrovir
pseudotyp
analyz
sprotein
sarscov
analysi
comparison
independ
studi
use
replic
compet
cov
show
sprotein
bear
pseudotyp
adequ
reflect
cell
tropism
receptor
attach
factor
usag
rout
entri
cov
sprotein
deriv
found
sarscov
bear
pseudotyp
infect
rel
broad
rang
cell
lead
us
conclus
sarscov
might
target
organ
lung
infect
patient
inde
subsequ
studi
examin
tissu
sar
patient
confirm
sarscov
target
varieti
organ
entri
sarscov
pseudotyp
replic
compet
viru
inhibit
compound
imped
acidif
endosom
compart
suggest
low
ph
might
trigger
structur
rearrang
sarscov
pivot
membran
fusion
howev
subsequ
studi
reveal
acid
environ
requir
activ
cellular
cathepsin
proteas
cleav
sarscov
possibl
cleavag
found
requir
infecti
cellular
entri
thu
sarscov
depend
entri
follow
novel
principl
offer
new
target
therapeut
intervent
entri
sarscov
strictli
depend
express
indic
cellular
receptor
sarscov
ectodomain
found
inhibit
sarscov
depend
entri
might
possibl
gener
deriv
inhibitor
compound
base
ectodomain
might
particularli
promis
propos
downmodul
sarscov
infect
respons
much
sar
patholog
prevent
applic
solubl
ectodomain
promot
entri
sarscov
viral
entri
enhanc
sprotein
bind
lectin
dcsign
dcsignr
studi
indic
dcsign
dcsignr
augment
infect
allow
infecti
entri
absenc
howev
anoth
studi
employ
replic
compet
sarscov
report
dcsignr
function
viral
receptor
case
interest
analyz
polymorph
dcsignr
neck
region
frequent
found
modul
risk
outcom
sarscov
infect
sarscov
share
receptor
dcsigndcsignr
attach
factor
group
observ
employ
infect
consequ
enter
target
cell
sarscov
induc
sever
diseas
pose
varieti
interest
question
accessori
gene
respons
differ
pathogen
nine
present
sarscov
compar
one
sarscov
engag
differenti
potenti
differ
associ
differ
pathogen
sensit
inhibitor
chimer
protein
gener
induc
neutral
antibodi
virus
develop
vaccin
receptor
experi
transient
transfect
non
permiss
hela
cell
inde
suggest
could
use
coreceptor
entri
data
shown
thorough
compar
analysi
sarscov
infecti
entri
includ
establish
anim
model
infect
requir
answer
question
